HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

Get your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
159 Doctors Online

By proceeding, I accept the Terms and Conditions

Dr. Andrew Rynne
MD
Dr. Andrew Rynne

Family Physician

Exp 50 years

HCM Blog Instant Access to Doctors
HCM BlogQuestions Answered
HCM Blog Satisfaction

Suggest Treatment For Intramedullary Tumor

HISTOPATHOLOGY
Speciman:
INTRAMEDULLARY TUMOR D5,D6,D7
Macroscopic description:
received multiple(more than 15) grey white soft tissue aggreating to 2cm across.
-all
DR.SAN/RS/AA
Microscopic:
Section show of portions of neoplasm composed of ovsl cells arranged diffusely with areas showing perivascular distribution of cells.The cells show pale cytoplasm and round to oval nuclei.
Mitosis not evident.No necrosis seen.
Alcian Blue-negative
IMPRESSION:
CONSISTENT WITH EPENDYMOMAGRADE II ;INTRAMEDULLARY TUMOR D5,D6,D7
Tue, 20 May 2014
Report Abuse
Oncologist,  's  Response
The patient has Ependymoma and needs imaging of entire CNS (central nervous system) axis [that is MRI of brain and spinal cord] as the intra-medullary ependymoma may represent drop metastasis from intra-cranial primary in the brain.
If there is no evidence of disease elsewhere in the CNS, patient should be given radiation therapy at the site of primary disease.
I find this answer helpful
Note: For further queries related to kidney problems Click here.
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer. For a more detailed, immediate answer, try our premium service [Sample answer]
Share on
 

Recent questions on Lymphatic system


Loading Online Doctors....
Suggest Treatment For Intramedullary Tumor

The patient has Ependymoma and needs imaging of entire CNS (central nervous system) axis [that is MRI of brain and spinal cord] as the intra-medullary ependymoma may represent drop metastasis from intra-cranial primary in the brain. If there is no evidence of disease elsewhere in the CNS, patient should be given radiation therapy at the site of primary disease.